XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.20.2

9. Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2020
Segment Reporting [Abstract] |
9. Segment Information | Aemetis recognizes two reportable geographic segments: “North America” and “India.” The “North America” operating segment includes the Keyes Plant, the Riverbank Cellulosic Ethanol Facility, the Biogas Project, the Goodland Plant and the research and development facility in Minnesota. The “India” operating segment includes the Kakinada Plant, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Company’s biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly. Summarized financial information by reportable segment for the three and nine months ended September 30, 2020 and 2019 follows:
|  | Three months ended September 30, 2020 |  |  | Three months ended September 30, 2019 |
|  | North America |  |  | India |  |  | Total Consolidated |  |  | North America |  |  | India |  |  | Total Consolidated |
Revenues |  | $ | 33,131 |  |  | $ | 7,792 |  |  | $ | 40,923 |  |  | $ | 37,820 |  |  | $ | 19,569 |  |  | $ | 57,389 |
Cost of goods sold |  |  | 33,534 |  |  |  | 6,618 |  |  |  | 40,152 |  |  |  | 37,990 |  |  |  | 15,417 |  |  |  | 53,407 |
Gross (loss) profit |  |  | (403 | ) |  |  | 1,174 |  |  |  | 771 |  |  |  | (170 | ) |  |  | 4,152 |  |  |  | 3,982 |
Other Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development expenses |  |  | 37 |  |  |  | - |  |  |  | 37 |  |  |  | 37 |  |  |  | - |  |  |  | 37 |
Selling, general and administrative expenses |  |  | 4,340 |  |  |  | 223 |  |  |  | 4,563 |  |  |  | 2,716 |  |  |  | 1,813 |  |  |  | 4,529 |
Interest expense |  |  | 6,461 |  |  |  | 9 |  |  |  | 6,470 |  |  |  | 6,293 |  |  |  | 49 |  |  |  | 6,342 |
Accretion of Series A preferred units |  |  | 1,765 |  |  |  | - |  |  |  | 1,765 |  |  |  | 589 |  |  |  | - |  |  |  | 589 |
Other (income) expense |  |  | 155 |  |  |  | (2 | ) |  |  | 153 |  |  |  | (265 | ) |  |  | (24 | ) |  |  | (289 | )
Income (loss) before income taxes |  | $ | (13,161 | ) |  | $ | 944 |  |  | $ | (12,217 | ) |  | $ | (9,540 | ) |  | $ | 2,314 |  |  | $ | (7,226 | )
Capital expenditures |  | $ | 6,187 |  |  | $ | 113 |  |  | $ | 6,300 |  |  | $ | 3,664 |  |  | $ | 351 |  |  | $ | 4,015 |
Depreciation |  |  | 1,085 |  |  |  | 168 |  |  |  | 1,253 |  |  |  | 942 |  |  |  | 161 |  |  |  | 1,103 |
|  | For the nine months ended September 30, 2020 |  |  | For the nine months ended September 30, 2019 |
|  | North America |  |  | India |  |  | Total Consolidated |  |  | North America |  |  | India |  |  | Total Consolidated |
Revenues |  | $ | 114,226 |  |  | $ | 14,001 |  |  | $ | 128,227 |  |  | $ | 113,942 |  |  | $ | 35,954 |  |  | $ | 149,896 |
Cost of goods sold |  |  | 101,231 |  |  |  | 12,599 |  |  |  | 113,830 |  |  |  | 113,440 |  |  |  | 29,552 |  |  |  | 142,992 |
Gross profit |  |  | 12,995 |  |  |  | 1,402 |  |  |  | 14,397 |  |  |  | 502 |  |  |  | 6,402 |  |  |  | 6,904 |
Other Expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development expenses |  |  | 175 |  |  |  | - |  |  |  | 175 |  |  |  | 160 |  |  |  | - |  |  |  | 160 |
Selling, general and administrative expenses |  |  | 11,206 |  |  |  | 1,342 |  |  |  | 12,548 |  |  |  | 9,972 |  |  |  | 2,743 |  |  |  | 12,715 |
Interest expense |  |  | 19,490 |  |  |  | 44 |  |  |  | 19,534 |  |  |  | 18,805 |  |  |  | 332 |  |  |  | 19,137 |
Accretion of Series A preferred units |  |  | 4,087 |  |  |  | - |  |  |  | 4,087 |  |  |  | 1,509 |  |  |  | - |  |  |  | 1,509 |
Loss contingency on litigation |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 6,200 |  |  |  | - |  |  |  | 6,200 |
Other expense (income) |  |  | 416 |  |  |  | (23 | ) |  |  | 393 |  |  |  | (228 | ) |  |  | (773 | ) |  |  | (1,001 | )
Income (loss) before income taxes |  | $ | (22,379 | ) |  | $ | 39 |  |  | $ | (22,340 | ) |  | $ | (35,916 | ) |  | $ | 4,100 |  |  | $ | (31,816 | )
Capital expenditures |  | $ | 13,571 |  |  | $ | 1,350 |  |  | $ | 14,921 |  |  | $ | 4,249 |  |  | $ | 804 |  |  | $ | 5,053 |
Depreciation |  |  | 3,030 |  |  |  | 485 |  |  |  | 3,515 |  |  |  | 2,883 |  |  |  | 454 |  |  |  | 3,337 |
North America: During the three and nine months ended September 30, 2020, the Company amended the Corn Procurement and Working Capital Agreement and the J.D. Heiskell Purchasing Agreement to procure corn from J.D. Heiskell and sell all WDG and corn oil the Company produces to J.D. Heiskell. Sales of ethanol, WDG, corn oil, and high-grade alcohol to two customers accounted for 72% and 24% of the Company’s North America segment revenues for the three months ended September 30, 2020. Sales to three customers accounted for 45%, 32% and 11% of the Company’s North America segment revenues for the nine months ended September 30, 2020. During the three and nine months ended September 30, 2019, the Company’s revenues from ethanol, WDG, and corn oil were made pursuant to the Corn Procurement and Working Capital Agreement. Sales of ethanol, WDG, and corn oil to J.D. Heiskell accounted for 98.3% and 99.3% of the Company’s North America segment revenues for the three and nine months ended September 30, 2019, respectively. India. During the three months ended September 30, 2020, two biodiesel customers accounted for 56% and 26% of the Company’s consolidated India segment revenues while none of the refined glycerin customers accounted for more than 10%, compared to three biodiesel customers accounting for 41%, 16% and 15% of the Company’s consolidated India segment revenues and none of the refined glycerin customers accounting for more than 10% of such revenues during the three months ended September 30, 2019. During the nine months ended September 30, 2020, two biodiesel customers accounted for 51% and 33%, of the Company’s consolidated India segment revenues while none of the refined glycerin customers accounted for more than 10% of such revenues, compared to three biodiesel customers accounted for 29%, 18% and 15% of the Company’s consolidated India segment revenues while none of the refined glycerin customers accounted for more than 10% of such revenues during the nine months ended September 30, 2019. Total assets by segment consist of the following:
|  | As of |
|  | September 30, |  |  | December 31, |
|  | 2020 |  |  | 2019 |
North America |  | $ | 105,619 |  |  | $ | 82,990 |
India |  |  | 16,551 |  |  |  | 16,906 |
Total Assets |  | $ | 122,170 |  |  | $ | 99,896 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration